🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of the Feasibility and Organisational Impact of a Care Pathway Incorporating the MultiSense® Medical Device for Post-operative Home Monitoring of Elderly Patients.

RecruitingNAAges 65 Years - anyAllRhythm Diagnostic Systems
NCT07514286 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Assessing the clinical and organisational impact of a home-based post-operative monitoring strategy incorporating the MultiSense® device involving 80 patients aged 65 years and over who have undergone major surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria : * Patient aged 65 or over * Patient eligible for remote monitoring using the MultiSense® device * No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care * Subject affiliated with a health insurance scheme * Subject able to read and understand English * Subject who has signed an informed consent form * Subjects indicated for scheduled surgery * Patients indicated for scheduled surgery : * Transverse colectomy, by laparotomy * Hepatic laparoscopy * Laparoscopic or laparoscopic liver surgery (code hlfc or hlfa for procedures) * Hysterectomy * Adnexectomy * Parietal surgery (eventration) * Rectal resection * Right and left colectomy * Stoma closure by direct approach Exclusion Criteria : * Patients already participating in an interventional clinical trial. * Patients subject to legal protection measures, guardianship, curatorship, or deprived of their liberty by judicial or administrative decision. * Patients hospitalised without consent. * Patients unable to complete a questionnaire and without a close relative to assist them in using the solution. * Patients admitted to or residing in a health or social care facility (other than for the surgery itself). * Persons admitted to or residing in a health or social care institution (other than for the surgery itself); * Persons unable to give their free and informed consent.
💊

What it tests

  • Monitoring by MultiSense
📍

Where

4 sites
Western Cancer Institute of Angers
Angers, France
Bergonié Insititute
Bordeaux, France
Inter-municipal Hospital Centre of Mont-de-marsan
Mont-de-Marsan, France
Western Cancer Institute of Nantes
Nantes, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy